Juergen Schwiezer to retire from Roche Diagnostics
This article was originally published in Clinica
Juergen Schwiezer, CEO of Roche’s diagnostics division, has announced he will retire at the end of the year. Meanwhile, Daniel O’Day will become chief operating officer of Roche Diagnostics on January 1 2010. Mr O’Day is currently head of the company’s molecular diagnostics division. Mr Schwiezer joined Boehringer Mannheim in 1976 and was appointed head of its executive committee in 1995. He became a member of the executive committee of Roche Germany in 1998, and has headed the diagnostics division since 2008.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.